logo

Automated External Defibrillators Recalled due to Potential Software Defect.

The  Defibtech Lifeline and ReviveR Automated External Defibrillators (AEDs) were recalled after evidence surfaced of a potential software glitch surfaced.  This defect may, in fact, cancel the shock that the AEDs are constructed to provide.

AEDs are commonly used by EMTs to resuscitate victims who have experienced sudden cardiac arrest and are unconscious, unresponsive and not breathing.

EMTs and Risk Managers should be aware that the specific AEDs included in the recall are:
-Model DDU-100 series with software version 2.004 or earlier, sold under the brand names Lifeline and ReviveR.
-AEDs using software version 2.004 or earlier may cause the device to cancel shock during the charging process.

FDA advises, “Defibtech will provide customers with a free software upgrade. Because the conditions that may lead to a canceled shock occur rarely, it is recommended that customers keep their AEDs in service during the software upgrade process. Full instructions and recommendations are being mailed to affected customers. Defibtech is responsible for contacting all end users unless a distributor has agreed to contact their accounts directly regarding this field correction”

Latest News from Pharma-Watch

FDA convenes to determine Fosamax bone fracture dangers

The New York Times Reports: In light of evidence linking the long-term use of Fosamax and femur fractures, the FDA said it plans to convene Friday to determine whether it will recommend suspending the use of the osteoporosis drug.

Spine Specialists Discredit Medtronic Bone Growth Product

June 29th, 2011 “It harms patients to have biased and corrupted research published…It harms patients to have unaccountable special interests permeate medical research,” read an excerpt from an

CT Brain Perfusion Scan Risks

The FDA released an advisory to consumers in October regarding the CT Bran Profusion Scan manufactured by GE. The advisory states that the scans default radiation therapy is set to high for most patient

Risk of death found in sleeping pill use -- Scripps

Scripps Study: Sleeping pills believed a cause of 500,000 premature deaths annually (March 1, 2012) Pick 10 people at random and ask them if they take sleeping pills. Chances are at least one of them

FDA pulls approval of Avastin breast cancer drug

Avastin no longer allowed for breast cancer The U.S. Food & Drug Administration has revoked its approval of Avastin after concluding the metastatic breast cancer treatment did nothing to control tumor